PIRS - ピエリス・ファ―マシュ―ティカルズ (Pieris Pharmaceuticals Inc.)

PIRSのニュース

   Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update - Stocks News Feed  2020/11/04 12:39:11 Stocks News Feed
Share this Stock InformationCOMPANY TO HOST AN INVESTOR CONFERENCE CALL ON WEDNESDAY, NOVEMBER 4, 2020 AT 8:00 AM EST PRS-060/AZD1402 first regulatory submission for global phase 2a study has been made; site initiation and patient screening expected this year PRS-343 in-use studies requested by FDA are completed; forthcoming meeting with FDA to align on path… Read More »Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
   Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Expected to Announce Quarterly Sales of $8.99 Million  2020/10/24 12:14:43 The Olympia Report
Analysts forecast that Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) will report sales of $8.99 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Pieris Pharmaceuticals’ earnings. The lowest sales estimate is $7.50 million and the highest is $10.47 million. Pieris Pharmaceuticals reported sales of $15.13 million in the same quarter last year, […]
   Pieris Pharmaceuticals (NASDAQ:PIRS) Stock Price Up 5%  2020/10/21 10:36:50 Zolmax News
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)’s share price rose 5% during mid-day trading on Monday . The stock traded as high as $2.53 and last traded at $2.50. Approximately 558,991 shares changed hands during trading, an increase of 20% from the average daily volume of 467,441 shares. The stock had previously closed at $2.38. A number of […]
   Zacks: Brokerages Anticipate Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Will Post Quarterly Sales of $8.99 Million  2020/10/21 01:46:44 US Banking News
Equities research analysts forecast that Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) will post sales of $8.99 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Pieris Pharmaceuticals’ earnings. The lowest sales estimate is $7.50 million and the highest is $10.47 million. Pieris Pharmaceuticals reported sales of $15.13 million during […]
   Here's What Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Shareholder Ownership Structure Looks Like  2020/09/28 16:50:08 Yahoo Finance
The big shareholder groups in Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) have power over the company. Insiders often…
   Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update - Stocks News Feed  2020/11/04 12:39:11 Stocks News Feed
Share this Stock InformationCOMPANY TO HOST AN INVESTOR CONFERENCE CALL ON WEDNESDAY, NOVEMBER 4, 2020 AT 8:00 AM EST PRS-060/AZD1402 first regulatory submission for global phase 2a study has been made; site initiation and patient screening expected this year PRS-343 in-use studies requested by FDA are completed; forthcoming meeting with FDA to align on path… Read More »Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
   Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Expected to Announce Quarterly Sales of $8.99 Million  2020/10/24 12:14:43 The Olympia Report
Analysts forecast that Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) will report sales of $8.99 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Pieris Pharmaceuticals’ earnings. The lowest sales estimate is $7.50 million and the highest is $10.47 million. Pieris Pharmaceuticals reported sales of $15.13 million in the same quarter last year, […]
   Pieris Pharmaceuticals (NASDAQ:PIRS) Stock Price Up 5%  2020/10/21 10:36:50 Zolmax News
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)’s share price rose 5% during mid-day trading on Monday . The stock traded as high as $2.53 and last traded at $2.50. Approximately 558,991 shares changed hands during trading, an increase of 20% from the average daily volume of 467,441 shares. The stock had previously closed at $2.38. A number of […]
   Zacks: Brokerages Anticipate Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Will Post Quarterly Sales of $8.99 Million  2020/10/21 01:46:44 US Banking News
Equities research analysts forecast that Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) will post sales of $8.99 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Pieris Pharmaceuticals’ earnings. The lowest sales estimate is $7.50 million and the highest is $10.47 million. Pieris Pharmaceuticals reported sales of $15.13 million during […]
   Here's What Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Shareholder Ownership Structure Looks Like  2020/09/28 16:50:08 Yahoo Finance
The big shareholder groups in Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) have power over the company. Insiders often…
   Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update - Stocks News Feed  2020/11/04 12:39:11 Stocks News Feed
Share this Stock InformationCOMPANY TO HOST AN INVESTOR CONFERENCE CALL ON WEDNESDAY, NOVEMBER 4, 2020 AT 8:00 AM EST PRS-060/AZD1402 first regulatory submission for global phase 2a study has been made; site initiation and patient screening expected this year PRS-343 in-use studies requested by FDA are completed; forthcoming meeting with FDA to align on path… Read More »Pieris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
   Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Expected to Announce Quarterly Sales of $8.99 Million  2020/10/24 12:14:43 The Olympia Report
Analysts forecast that Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) will report sales of $8.99 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Pieris Pharmaceuticals’ earnings. The lowest sales estimate is $7.50 million and the highest is $10.47 million. Pieris Pharmaceuticals reported sales of $15.13 million in the same quarter last year, […]
   Pieris Pharmaceuticals (NASDAQ:PIRS) Stock Price Up 5%  2020/10/21 10:36:50 Zolmax News
Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS)’s share price rose 5% during mid-day trading on Monday . The stock traded as high as $2.53 and last traded at $2.50. Approximately 558,991 shares changed hands during trading, an increase of 20% from the average daily volume of 467,441 shares. The stock had previously closed at $2.38. A number of […]
   Zacks: Brokerages Anticipate Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Will Post Quarterly Sales of $8.99 Million  2020/10/21 01:46:44 US Banking News
Equities research analysts forecast that Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) will post sales of $8.99 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Pieris Pharmaceuticals’ earnings. The lowest sales estimate is $7.50 million and the highest is $10.47 million. Pieris Pharmaceuticals reported sales of $15.13 million during […]
   Here's What Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Shareholder Ownership Structure Looks Like  2020/09/28 16:50:08 Yahoo Finance
The big shareholder groups in Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) have power over the company. Insiders often…

calendar